MC1281A1 - Agents diuretiques - Google Patents

Agents diuretiques

Info

Publication number
MC1281A1
MC1281A1 MC791405A MC1405A MC1281A1 MC 1281 A1 MC1281 A1 MC 1281A1 MC 791405 A MC791405 A MC 791405A MC 1405 A MC1405 A MC 1405A MC 1281 A1 MC1281 A1 MC 1281A1
Authority
MC
Monaco
Prior art keywords
compound
acid
diuretic
represent
potassium
Prior art date
Application number
MC791405A
Other languages
English (en)
French (fr)
Inventor
A Baum
A Wick
M Fernex
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1281A1 publication Critical patent/MC1281A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Confectionery (AREA)
MC791405A 1978-09-12 1979-09-06 Agents diuretiques MC1281A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH954778A CH639273A5 (de) 1978-09-12 1978-09-12 Diuretische mittel.

Publications (1)

Publication Number Publication Date
MC1281A1 true MC1281A1 (fr) 1980-07-22

Family

ID=4353125

Family Applications (1)

Application Number Title Priority Date Filing Date
MC791405A MC1281A1 (fr) 1978-09-12 1979-09-06 Agents diuretiques

Country Status (25)

Country Link
US (1) US4265893A (enExample)
EP (1) EP0009657B1 (enExample)
JP (1) JPS5538397A (enExample)
AT (1) ATE1216T1 (enExample)
AU (1) AU525735B2 (enExample)
CA (1) CA1108537A (enExample)
CH (1) CH639273A5 (enExample)
CU (1) CU35124A (enExample)
DE (2) DE2936244A1 (enExample)
DK (1) DK379579A (enExample)
ES (1) ES484060A1 (enExample)
FR (1) FR2435946A1 (enExample)
GB (1) GB2032275A (enExample)
GR (1) GR73090B (enExample)
HU (1) HU183090B (enExample)
IE (1) IE48687B1 (enExample)
IL (1) IL58178A (enExample)
IT (1) IT1122376B (enExample)
LU (1) LU81664A1 (enExample)
MC (1) MC1281A1 (enExample)
NL (1) NL7906766A (enExample)
NZ (1) NZ191485A (enExample)
PH (1) PH14733A (enExample)
SE (1) SE7907540L (enExample)
ZA (1) ZA794692B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3143471A1 (de) * 1981-11-03 1983-05-19 Beiersdorf Ag, 2000 Hamburg "neue pharmazeutische zusammensetzung"
DE3241134C2 (de) * 1981-11-09 1996-04-11 Mallinckrodt Veterinary Inc N Verfahren zur Herstellung von 2,4-Diamino-5-benzylpyrimidinen sowie Zwischenprodukte des Verfahrens
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH591456A5 (enExample) 1973-09-12 1977-09-15 Hoffmann La Roche

Also Published As

Publication number Publication date
EP0009657A1 (de) 1980-04-16
IE48687B1 (en) 1985-04-17
DE2963170D1 (en) 1982-08-12
NL7906766A (nl) 1980-03-14
EP0009657B1 (de) 1982-06-23
CU35124A (en) 1982-08-24
ATE1216T1 (de) 1982-07-15
ES484060A1 (es) 1980-10-01
IL58178A0 (en) 1979-12-30
CH639273A5 (de) 1983-11-15
CA1108537A (en) 1981-09-08
AU5060679A (en) 1980-03-20
SE7907540L (sv) 1980-03-13
IL58178A (en) 1982-09-30
US4265893A (en) 1981-05-05
IE791722L (en) 1980-03-12
GB2032275A (en) 1980-05-08
HU183090B (en) 1984-04-28
FR2435946B1 (enExample) 1983-03-18
AU525735B2 (en) 1982-11-25
DK379579A (da) 1980-03-13
JPS5538397A (en) 1980-03-17
NZ191485A (en) 1984-07-06
ZA794692B (en) 1980-08-27
PH14733A (en) 1981-11-19
IT7924808A0 (it) 1979-07-31
DE2936244A1 (de) 1980-03-20
GR73090B (enExample) 1984-02-01
LU81664A1 (de) 1981-04-17
FR2435946A1 (fr) 1980-04-11
IT1122376B (it) 1986-04-23

Similar Documents

Publication Publication Date Title
DE1795836C2 (de) 3-MethyI-2,3,4,4a-tetrahydro-lH- pyrazine [1,2-f] phenanthridin
CH630260A5 (fr) Compositions antibiotiques a base d'une tetracycline.
FR2472388A1 (fr) Compositions pharmaceutiques contenant un produit corticosteroide
FR2591481A1 (fr) Compositions pharmaceutiques douees d'activites vasodilatatrice et anti-anoxique comprenant une coenzyme ubiquinone et un vasodilatateur.
MC1281A1 (fr) Agents diuretiques
LU86403A1 (fr) 5-pyrimidine-carboxamides et traitement de la leucemie et des tumeurs avec ces derniers
FR2462909A1 (fr) Composition dermatologique a base de derives de l'acide apovincaminique ou d'apovincine et ses derives pour le traitement des maladies de la peau, accompagnees d'une proliferation cellulaire, telles que le psoriasis
CH644015A5 (fr) Solution aqueuse injectable a base d'oxytetracycline.
AU2020368463A1 (en) Compositions comprising quinone and/or quinol and methods of preparations and use thereof
EP0575481B1 (fr) Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4
EP0412901A2 (fr) Utilisation de trifluorométhyl-phényltétrahydropyridines pour la préparation de médicaments destinés à combattre les troubles de la motricité intestinale
CA1059913A (fr) Compositions pharmaceutiques
EP0161249A1 (fr) Enamides acyles et compositions pharmaceutiques les contenant
DE69121940T2 (de) Derivate des Hydantoins zur Verwendung als hypoglycemische und/oder hypolipidemische Wirkstoffe
EP1998779A2 (fr) Utilisation du (3s)-n-hydroxy-4-({4-ý(4-hydroxy-2-butynyl)oxy]phényl}sulfonyl)-2,2-diméthyl-3-thiomorpholine carboxamide ou du (s)-n-hydroxy-4-(4-but-2-ynyloxy-benzenesulfonyl) -2,2-dimethyl-thiomorpholine -3-carboxamide dans le traitement de pathologies inflammatoires cutanées
US4349547A (en) Suppressing obesity and over-secretion of insulin with 2-(α-hydroxy-m-trifluoromethylbenzyl)azetidine
BE1001263A4 (fr) Procede en vue de provoquer la regression de la leucemie et l'inhibition de la croissance des tumeurs chez les mammiferes.
BE887922A (fr) Compositions pharmaceutiques a activites mucolytique, bronchosecretolytique et antibronchospastique
FR2551755A1 (fr) Sels de dioxyde de benzothiazine cristallin et compositions pharmaceutiques les contenant
EP0003456A1 (fr) Dérivés d'amino-3-cardénolides, procédé pour leur préparation, et médicaments les contenant
LU83775A1 (fr) Derives de naphtyridine,leur preparation et leur application en therapeutique
FR2512672A1 (fr) Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant
CA2028986A1 (fr) Application du n-methyl (pyridyl-3)-2 tetrahydrothiopyrannecarbothioamide-2-oxyde-1 a la preparation de medicaments destines au traitement de l'insuffisance coronarienne
FR2485372A1 (fr) Composition pharmaceutique pour le traitement des etats d'intoxication alcoolique aigue a base de 5-oxo-2-pyrrolidone carboxylate de pyridoxine et procede de preparation de ce dernier
BE880487A (fr) Procede de preparation de quinazolines substituees, quinazolines ainsi obtenues et methode de traitement de l'hypertension les utilisant

Legal Events

Date Code Title Description
YP Annual fee paid